1,807
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Association between the FMR1 CGG repeat lengths and the severity of idiopathic primary ovarian insufficiency: a meta analysis

, , , , &
Pages 3116-3122 | Received 28 May 2019, Accepted 04 Jul 2019, Published online: 27 Jul 2019

References

  • Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360:606–614.
  • Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf). 2008;68:499–509.
  • De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet. 2010;376:911–921.
  • Sullivan SD, Welt C, Sherman S. FMR1 and the continuum of primary ovarian insufficiency. Semin Reprod Med. 2011;29:299–307.
  • Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604–606.
  • Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update. 2005;11:391–410.
  • van Kasteren YM, Hundscheid RD, Smits AP, et al. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease? Hum Reprod. 1999;14:2455–2459.
  • Qin Y, Jiao X, Simpson JL, et al. Genetics of primary ovarian insufficiency: new developments and opportunities. Hum Reprod Update. 2015;21:787–808.
  • Wittenberger MD, Hagerman RJ, Sherman SL. The FMR1 premutation and reproduction. Fertil Steril. 2007;87:456–465.
  • Tejada MI, García-Alegría E, Bilbao A, et al. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome. Menopause. 2008;15:945–949.
  • 1.Allen EG, Sullivan AK, Marcus M, et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod. 2007;22:2142–2152.
  • Spath MA, Feuth TB, Smits AP, et al. Predictors and risk model development for menopausal age in fragile X premutation carriers. Genet Med. 2011;13:643–650.
  • Bodega B, Bione S, Dalprà L, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod. 2006;21:952–957.
  • Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet. 2005;117:376–382.
  • Streuli I, Fraisse T, Ibecheole V, et al. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil and Steril. 2009;92:464–470.
  • Bennett CE, Conway GS, Macpherson JN, et al. Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failure. Hum Reprod. 2010;25:1335–1338.
  • Ishizuka B, Okamoto N, Hamada N, et al. Number of CGG repeats in the FMR1 gene of Japanese patients with primary ovarian insufficiency. Fertil Steril. 2011;96:1170–1174.
  • Pastore L, Young SL, Manichaikul A, et al. Distribution of the FMR1 gene in females by race-ethnicity: women with diminished ovarian reserve versus women with normal fertility (SWAN study). Fertil Steril. 2017;107:205–211.
  • Eslami A, Farahmand K, Totonchi M, et al. FMR1 premutation: not only important in premature ovarian failure but also in diminished ovarian reserve. Human Fertil. 2016;20:1–6.
  • Barasoain M, Barrenetxea G, Huerta I, et al. Study of FMR1 gene association with ovarian dysfunction in a sample from the Basque Country. Gene 2013;521:145–149.
  • De Geyter C, M’Rabet N, De Geyter J, et al. Similar prevalence of expanded CGG repeat lengths in the fragile X mental retardation I gene among infertile women and among women with proven fertility: a prospective study. Genet Med. 2014;16:374–378.
  • Murray A, Schoemaker MJ, Bennett CE, et al. Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency. Genet Med. 2014;16:19–24.
  • Chatterjee S, Maitra A, Kadam S, et al. CGG repeat sizing in the FMR1 gene in Indian women with premature ovarian failure. Reprod Biomed Online. 2009;19:281–286.
  • Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study-preliminary data. Am J Med Genet. 1999;83:322–325.
  • Uzielli ML, Guarducci S, Lapi E, et al. Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data. Am J Med Genet. 1999;84:300–303.
  • Gleicher N, Weghofer A, Oktay K, et al. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod Biomed Online. 2009;19:385–390.
  • Lin L, Yu D, Du X, et al. Research of FMR1 gene CGG repeat polymorphism with premature ovarian failure. J Hebei Med Univ. 2013;34:1031–1034.
  • Ye Y, Lan X, Cong J, et al. Analysis of CGG repeats in FMR1 in Chinese women with idiopathic premature ovarian failure. Reprod Biomed Online. 2014;29:382–387.
  • Guo T, Qin Y, Jiao X, et al. FMR1 premutation is an uncommon explanation for premature ovarian failure in Han Chinese. PLOS One. 2014;9:e103316.
  • Pastore LM, Young SL, Baker VL, et al. Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reprod Sci. 2012;19:1226–1231.
  • Rezvaneh A, Davood OM, Hamid G, et al. Premutations of FMR1 CGG repeats are not related to idiopathic premature ovarian failure in Iranian patients: a case control study. Gene. 2018;676:189–194.
  • Espeche L, Violeta C, Ianina F, et al. Distribution of FMR1 and FMR2 repeats in Argentinean patients with primary ovarian insufficiency. Genes. 2017;8:194–203.
  • Karimov CB, Moragianni VA, Cronister A, et al. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Hum Reprod. 2011;26:2077–2083.
  • Sherman S, Pletcher BA, Driscoll DA. Fragile X syndrome: diagnostic and carrier testing. Genet Med. 2005;7:584–587.
  • Aittomaki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995;82:959–968.
  • Kovanci E, Rohozinski J, Simpson JL, et al. Growth differentiating factor-9 mutations may be associated with premature ovarian failure. Fertil Steril. 2007;87:143–146.
  • Weiss K, Orr-Urtreger A, Kaplan Ber I, et al. Ethnic effect on FMR1 carrier rate and AGG repeat interruptions among Ashkenazi women. Gen Med. 2014;16:940–944.
  • Genereux DP, Laird CD. Why do fragile X carrier frequencies differ between Asian and non-Asian populations? Genes Genet Syst. 2013;88:211–224.
  • Crawford DC, Meadows KL, Newman JL, et al. Prevalence of the fragile X syndrome in African-Americans. Am J Med Genet. 2002;110:226–233.